» Articles » PMID: 35328758

A Study on the Effect of the Substituent Against PAK4 Inhibition Using In Silico Methods

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Mar 25
PMID 35328758
Authors
Affiliations
Soon will be listed here.
Abstract

The intrinsic inductive properties of atoms or functional groups depend on the chemical properties of either electron-withdrawing groups (EWGs) or electron-donating groups (EDGs). This study aimed to evaluate in silico methods to determine whether changes in chemical properties of the compound by single atomic substitution affect the biological activity of target proteins and whether the results depend on the properties of the functional groups. We found an imidazo[4,5-b]pyridine-based PAK4 inhibitor, compound , as an initial hit compound with the well-defined binding mode for PAK4. In this study, we used both experimental and in silico methods to investigate the effect of atomic substitution on biological activity to optimize the initial hit compound. In biological assays, in the case of EWG, as the size of the halogen atom became smaller and the electronegativity increased, the biological activity IC value ranged from 5150 nM to inactive; in the case of EDG, biological activity was inactive. Furthermore, we analyzed the interactions of PAK4 with compounds, focusing on the hinge region residues, L398 and E399, and gatekeeper residues, M395 and K350, of the PAK4 protein using molecular docking studies and fragment molecular orbital (FMO) methods to determine the differences between the effect of EWG and EDG on the activity of target proteins. These results of the docking score and binding energy did not explain the differences in biological activity. However, the pair-interaction energy obtained from the results of the FMO method indicated that there was a difference in the interaction energy between the EWG and EDG in the hinge region residues, L398 and E399, as well as in M395 and K350. The two groups with different properties exhibited opposite electrostatic energy and charge transfer energy between L398 and E399. Additionally, we investigated the electron distribution of the parts interacting with the hinge region by visualizing the molecular electrostatic potential (MEP) surface of the compounds. In conclusion, we described the properties of functional groups that affect biological activity using an in silico method, FMO.

Citing Articles

Affinity Purification and Molecular Characterization of Angiotensin-Converting Enzyme (ACE)-Inhibitory Peptides from .

Su Y, Chen S, Liu S, Wang Y, Chen X, Xu M Mar Drugs. 2023; 21(10).

PMID: 37888457 PMC: 10608451. DOI: 10.3390/md21100522.


Synthesis, anti-amoebic activity and molecular docking simulation of eugenol derivatives against sp.

Zamli K, Hashim F, Razali S, Yusoff H, Mohamad H, Abdullah F Saudi Pharm J. 2023; 31(9):101703.

PMID: 37546528 PMC: 10400915. DOI: 10.1016/j.jsps.2023.101703.


Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis.

Yang S, Tang X, Wang L, Ni C, Wu Y, Zhou L Int J Mol Sci. 2022; 23(24).

PMID: 36555781 PMC: 9787584. DOI: 10.3390/ijms232416137.

References
1.
Kubillus M, Kubar T, Gaus M, rezac J, Elstner M . Parameterization of the DFTB3 method for Br, Ca, Cl, F, I, K, and Na in organic and biological systems. J Chem Theory Comput. 2016; 11(1):332-42. DOI: 10.1021/ct5009137. View

2.
Costa T, Stromblad S . Why is PAK4 overexpressed in cancer?. Int J Biochem Cell Biol. 2021; 138:106041. DOI: 10.1016/j.biocel.2021.106041. View

3.
Mazanetz M, Ichihara O, Law R, Whittaker M . Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method. J Cheminform. 2011; 3(1):2. PMC: 3032746. DOI: 10.1186/1758-2946-3-2. View

4.
Ge Y, Wych D, Samways M, Wall M, Essex J, Mobley D . Enhancing Sampling of Water Rehydration on Ligand Binding: A Comparison of Techniques. J Chem Theory Comput. 2022; 18(3):1359-1381. PMC: 9241631. DOI: 10.1021/acs.jctc.1c00590. View

5.
Costa T, Stromblad S . New control of the senescence barrier in breast cancer. Mol Cell Oncol. 2020; 7(2):1684129. PMC: 7051141. DOI: 10.1080/23723556.2019.1684129. View